↓ Skip to main content

Medicines and universal health coverage: challenges and opportunities

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#47 of 436)
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

policy
1 policy source
twitter
22 X users

Citations

dimensions_citation
47 Dimensions

Readers on

mendeley
124 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Medicines and universal health coverage: challenges and opportunities
Published in
Journal of Pharmaceutical Policy and Practice, February 2015
DOI 10.1186/s40545-015-0028-4
Pubmed ID
Authors

Maryam Bigdeli, Richard Laing, Göran Tomson, Zaheer-Ud-Din Babar

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 124 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Jordan 1 <1%
Brazil 1 <1%
Unknown 122 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 23%
Researcher 12 10%
Student > Ph. D. Student 9 7%
Student > Doctoral Student 9 7%
Student > Bachelor 8 6%
Other 18 15%
Unknown 40 32%
Readers by discipline Count As %
Medicine and Dentistry 21 17%
Pharmacology, Toxicology and Pharmaceutical Science 16 13%
Social Sciences 11 9%
Nursing and Health Professions 10 8%
Business, Management and Accounting 7 6%
Other 15 12%
Unknown 44 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 October 2020.
All research outputs
#2,152,812
of 23,671,454 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#47
of 436 outputs
Outputs of similar age
#27,837
of 258,461 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#3
of 10 outputs
Altmetric has tracked 23,671,454 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 436 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 258,461 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.